Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Nxera Pharma Co., Ltd. SOLTF

Set alert

Price alert · SOLTF

All alert types
8.50 USD 0.00 0.00%

At close · Oct 30

8.50 Day range 8.50
4.90 52-week range 8.50
YTD
+55.11%
1 year
+38.44%
Open
8.50
Prev close
8.50
Mkt cap
776.69M
Vol
100
Avg vol
85
EPS
-0.40
P/E
0.00
More statistics
Low
8.50
High
8.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SOLTF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.58 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -6.2×
FY 2016: -162×FY 2017: 18.2×FY 2018: -21.6×FY 2019: 117×FY 2020: 86.8×FY 2021: 157×FY 2022: 319×FY 2023: -16.2×FY 2024: -18.0×FY 2025: -6.2×
FY 2016 5y median -6.2× FY 2025
P/S 2.6×
FY 2016: 30.7×FY 2017: 9.3×FY 2018: 44.8×FY 2019: 17.2×FY 2020: 14.5×FY 2021: 9.0×FY 2022: 7.8×FY 2023: 9.1×FY 2024: 3.0×FY 2025: 2.6×
FY 2016 5y median 7.8× FY 2025
P/B 1.3×
FY 2016: 10.8×FY 2017: 6.1×FY 2018: 3.5×FY 2019: 3.7×FY 2020: 2.5×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 1.7×FY 2024: 1.3×FY 2025: 1.3×
FY 2016 5y median 1.7× FY 2025
P/FCF -24.9×
FY 2016: 57.7×FY 2017: 14.0×FY 2018: -56.3×FY 2019: 53.0×FY 2020: 28.1×FY 2021: 23.1×FY 2022: 12.6×FY 2023: -19.0×FY 2024: -9.4×FY 2025: -24.9×
FY 2016 5y median -9.4× FY 2025
EV/EBITDA -30.9×
FY 2016: 18.0×FY 2017: -117×FY 2018: -23.4×FY 2019: 62.9×FY 2020: 47.6×FY 2021: 15.7×FY 2022: 26.7×FY 2023: -24.7×FY 2024: 1167×FY 2025: -30.9×
FY 2016 5y median 15.7× FY 2025
EV/Sales 3.9×
FY 2016: 30.6×FY 2017: 8.9×FY 2018: 39.8×FY 2019: 15.8×FY 2020: 11.9×FY 2021: 7.3×FY 2022: 5.5×FY 2023: 11.1×FY 2024: 4.2×FY 2025: 3.9×
FY 2016 5y median 5.5× FY 2025
FCF Yield -4.0%
FY 2016: 1.7%FY 2017: 7.1%FY 2018: -1.8%FY 2019: 1.9%FY 2020: 3.6%FY 2021: 4.3%FY 2022: 7.9%FY 2023: -5.3%FY 2024: -10.7%FY 2025: -4.0%
FY 2016 5y median -4.0% FY 2025

Profitability

Gross Margin 60.7%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 52.5%FY 2019: 91.3%FY 2020: 91.4%FY 2021: 94.7%FY 2022: 94.1%FY 2023: 75.7%FY 2024: 73.6%FY 2025: 60.7%
FY 2016 5y median 75.7% FY 2025
Operating Margin -27.3%
FY 2016: 13.2%FY 2017: 65.5%FY 2018: -193.3%FY 2019: 3.9%FY 2020: 10.5%FY 2021: 21.3%FY 2022: 22.1%FY 2023: -74.6%FY 2024: -18.8%FY 2025: -27.3%
FY 2016 5y median -18.8% FY 2025
Net Margin -42.3%
FY 2016: -19.0%FY 2017: 51.0%FY 2018: -207.5%FY 2019: 14.7%FY 2020: 16.7%FY 2021: 5.7%FY 2022: 2.5%FY 2023: -56.3%FY 2024: -16.8%FY 2025: -42.3%
FY 2016 5y median -16.8% FY 2025
ROE -20.5%
FY 2016: -6.7%FY 2017: 33.4%FY 2018: -16.3%FY 2019: 3.2%FY 2020: 2.8%FY 2021: 1.8%FY 2022: 0.7%FY 2023: -10.8%FY 2024: -7.1%FY 2025: -20.5%
FY 2016 5y median -7.1% FY 2025
ROIC -5.5%
FY 2016: 1.1%FY 2017: 20.8%FY 2018: -9.1%FY 2019: 0.7%FY 2020: 1.1%FY 2021: 4.2%FY 2022: 1.3%FY 2023: -4.4%FY 2024: -3.8%FY 2025: -5.5%
FY 2016 5y median -3.8% FY 2025
ROA -9.3%
FY 2016: -3.3%FY 2017: 20.0%FY 2018: -11.4%FY 2019: 2.5%FY 2020: 1.9%FY 2021: 1.0%FY 2022: 0.4%FY 2023: -4.6%FY 2024: -3.2%FY 2025: -9.3%
FY 2016 5y median -3.2% FY 2025

Growth (YoY)

Revenue 2.8%
FY 2016: 122.0%FY 2017: 131.9%FY 2018: -79.7%FY 2019: 154.0%FY 2020: -9.1%FY 2021: 100.3%FY 2022: -12.1%FY 2023: -18.0%FY 2024: 125.9%FY 2025: 2.8%
FY 2016 FY 2025
Operating Income -49.1%
FY 2016: -3.1%FY 2017: 1052.5%FY 2018: -159.7%FY 2019: 105.2%FY 2020: 141.7%FY 2021: 306.8%FY 2022: -9.0%FY 2023: -377.2%FY 2024: 43.1%FY 2025: -49.1%
FY 2016 FY 2025
EPS (diluted) -157.3%
FY 2016: -349.7%FY 2017: 662.4%FY 2018: -173.3%FY 2019: 117.7%FY 2020: 0.7%FY 2021: -33.4%FY 2022: -62.7%FY 2023: -1982.7%FY 2024: 38.1%FY 2025: -157.3%
FY 2016 FY 2025
Free Cash Flow 66.3%
FY 2016: 117862.0%FY 2017: 188.5%FY 2018: -124.3%FY 2019: 203.7%FY 2020: 44.5%FY 2021: 51.0%FY 2022: 40.0%FY 2023: -163.5%FY 2024: -51.1%FY 2025: 66.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 3.1×FY 2017: 3.2×FY 2018: 5.5×FY 2019: 8.5×FY 2020: 14.1×FY 2021: 8.7×FY 2022: 17.1×FY 2023: 3.8×FY 2024: 3.7×FY 2025: 2.5×
FY 2016 5y median 3.8× FY 2025
Quick Ratio 1.9×
FY 2016: 3.4×FY 2017: 3.2×FY 2018: 5.7×FY 2019: 8.5×FY 2020: 13.9×FY 2021: 8.7×FY 2022: 17.1×FY 2023: 3.6×FY 2024: 3.1×FY 2025: 1.9×
FY 2016 5y median 3.6× FY 2025
Debt / Equity 0.9×
FY 2016: 0.4×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 1.1×FY 2024: 1.0×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
Net Debt / EBITDA -10.0×
FY 2016: -0.1×FY 2017: 4.9×FY 2018: 2.9×FY 2019: -5.5×FY 2020: -10.6×FY 2021: -3.8×FY 2022: -11.6×FY 2023: -4.4×FY 2024: 339×FY 2025: -10.0×
FY 2016 5y median -4.4× FY 2025
Interest Coverage -1.1×
FY 2016: 0.2×FY 2017: 25.9×FY 2018: 0.0×FY 2019: 0.8×FY 2020: 1.6×FY 2021: 1.0×FY 2022: 4.5×FY 2023: -3.8×FY 2024: -6.9×FY 2025: -1.1×
FY 2016 5y median -1.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31